Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The treatment pages refer only to FDA-registered 503A compounding pharmacies, and the terms and privacy policy name none. 2 more criteria also fail; see the table below.
At a glance
Better Med SpaTelehealth service
4/8criteria passed
Price
Semaglutide from $290 a month on a 3-month commitment; tirzepatide from $390
Sells
semaglutide, tirzepatide, liraglutide, and 12 more
Telehealth service. Passes 4 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.
A Chicago medical spa whose Illinois-only telehealth program sells semaglutide, tirzepatide and liraglutide weight loss memberships and a long list of peptide protocols, including sermorelin, tesamorelin and BPC-157, under a named medical director, alongside in-clinic aesthetic treatments.
The evidence behind each disposition in the table above, where it appears, and its date.
S1PASSEvery telehealth patient is evaluated by the medical team under the direction of Dr. Brett Brechner, DO, the board-certified physician and medical director, who prescribe only treatments that are clinically appropriate.Source: Better Med Spa's telehealth page; Better Med Spa's dr brechner page.
S2NOT VERIFIEDWhether a GLP-1 membership is paid before the medical evaluation did not resolve, because the telehealth answers say care begins with a virtual consultation that reviews the health history before approval, while each GLP-1 treatment page's booking button opens a membership cart on an outside booking service. The check is open.Source: Better Med Spa's telehealth page; Better Med Spa's semaglutide product page.
S3FAILNo filling pharmacy is named. The treatment pages refer only to FDA-registered 503A compounding pharmacies, and the terms and privacy policy name none.Source: Better Med Spa's BPC-157 product page; Better Med Spa's sermorelin product page; Better Med Spa's terms and conditions.
S4FAILThe telehealth page describes the weight loss program as using FDA-approved GLP-1 receptor agonists and says its telehealth medications are sourced from U.S. 503A pharmacies, which the treatment pages call FDA-registered 503A compounding pharmacies; the semaglutide page gives semaglutide and tirzepatide an FDA status of approved, and no GLP-1 page says the medications are compounded or not FDA-approved.Source: Better Med Spa's telehealth page; Better Med Spa's semaglutide product page; Better Med Spa's BPC-157 product page.
S5FAILThe BPC-157 page says its pharmacy's products undergo third-party testing, but no certificate of analysis or lot document is published on the treatment pages or the terms.Source: Better Med Spa's BPC-157 product page; Better Med Spa's semaglutide product page; Better Med Spa's terms and conditions.
S6PASS2117 N Halsted St, Chicago, IL 60614, printed as the privacy officer's address in the privacy policy and in the footer of every page. The terms name Chore LLC, doing business as Better Medspa and Wellness, and Illinois law.Source: Better Med Spa's privacy policy; Better Med Spa's contact page; Better Med Spa's terms and conditions.
S7PASSSemaglutide starts at $290 a month on a 3-month commitment, tirzepatide at $390, sermorelin at $200, tesamorelin at $400 and BPC-157 at $250. The semaglutide page's pricing section also asks buyers to contact the clinic or see its memberships page for current prices.Source: Better Med Spa's telehealth page; Better Med Spa's semaglutide product page; Better Med Spa's tirzepatide product page; Better Med Spa's sermorelin product page; Better Med Spa's tesamorelin product page; Better Med Spa's BPC-157 product page.
S8PASSNo FDA warning letter names Better Med Spa, Better Medspa and Wellness or Chore LLC, and no action has halted the business.Source: FDA warning-letter index.
Products shown on the seller's own pages at the recorded date: semaglutide, tirzepatide, liraglutide, semaglutide microdose, tirzepatide microdose, sermorelin, tesamorelin, CJC-1295 + ipamorelin, BPC-157, TB-500, GHK-Cu, NAD+, PT-141, testosterone replacement therapy, enclomiphene.
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.